Chemoimmunotherapy Combos “Game-Changing” in Frontline Metastatic NSCLC
October 30th 2020Nicholas Rohs, MD, discusses the progress made with chemoimmunotherapy combinations in frontline non–small cell lung cancer, future research directions, and emerging approaches that seek to propel progress in this disease.